Member Info for chester18

Morning Iglu,

As has been said many times on this board 'once the funding is in place this company will flourish'.

It's not going to be mega profits next week but the 3 to 5 year outlook is extremely promising. Anyone wanting to hold long term, tucked away in an ISA or SIPP is a good option.

The immediate situation is that the fully functioning company is probably worth :
short term 3 - 5p a share
Medium term 6 - 10p
Long term 10 - 20p

Even longer term who knows but in 5 years could be 50p to £1, that is if the company continues under it's own steam.

There is a high probability that as it grows and the profits start to mount up a far larger business may try a takeover.

But first things first, funding resolution this week please.

Chester.

RNS's was on the 4th September 2019 so 6 months past and with an agreed 12 month maximum time frame we are now on the downhill run. The news on a deal associated with that and the other two agreements could arrive at any time but an early conclusion of the 1st agreement is highly likely from the 4th June on wards ( 9 months ).

Maybe Inan's 'Tick Tock' is now very nearly reaching its final Ticks and Tocks ......

Chester.

For there to be shares available to buy there has to be sellers but what's good about TRX is there are plenty of buyers and the volumes are good.

It would be nice for news to drop this week.

Chester.

Morning Bermudashorts

I was mixing my USA trial info the 14 sites is by Renueron. I must admit I was presuming that the original Scancell trial with Dr. Keith Faltherty announced back in December 2015 would be the template for the new trial.

The original trial stated :

"The clinical study will assess the impact of adding SCIB1 to a checkpoint inhibitor in patients with late stage melanoma. The aim will be to improve the objective response rates of anti-PD-1 ("checkpoint inhibitor") monotherapy without adding additional toxicity. It is expected that the trial will enrol approximately 80 Stage 3/4 metastatic melanoma patients and commence in the second half of 2016, ending around 18 months later."

So it was a much bigger trial.

All I can hope is that the recruitment into this trial of eligible patients is more successful and speedier in the USA than in our one site in Nottingham.

Chester.

Should be :
"First patient approved and dosed" mid May to mid June...... not trial started....

Chester.

To start the trials in the 14 sites in the USA will take a while to organise and begin the training of medical staff. A positive thing will be the manufacture of the first few TriGrid 2's must be already be done or very close because of the UK approval being months back.

From the FDA passing of the Trigrid 2 to the first patient being screened and approved could be two to three months so my personal take is mid May to mid June for trial has started RNS.

Once that day dawns we will have the comfort of knowing that potentially some data from the trial is only a matter of a few months away.

That will be the most welcome news to all LTH's.

Chester.

Hi Bermudashorts

The difficulty in trying to squeeze big statements in to shortest words.

A) I don't like companies that RNS solely to support a share price position or range.

B) Institutional Investors holding say 4% can ask for a place on the board. That surely gives those companies a better indicator as to the general direction of a company.

C) There is a possibility that some early SCIB 1 / Combo data could be released inside 12 months. Also I would hope that the current AvidiMab collaborations do prove the lab data and bring about some licence agreements.

Hope that better covers my points.

Chester.

My central point is, that as a company Scancell has not and does not do things just to frustrate us investors. There have been circumstances beyond the company's control which has restricted the development of their science. For instance if the FDA had approved the Trigrid in early 2018 we would not be having these conversations.

I would expect that the major Institutional investors would be kept better informed that the general market and I include all us PI's as part of that market.

What we do know, because we've been told, is that it is the data from clinical trials that is the most important goal of the company. It is only when that data unequivocally shows that SCIB 1 in Combo and MODI 1 as a stand alone demonstrates that what happened in the laboratory actually happens in humans will the true value be released.

I'm invested in a science lead business and glad that it's not dominated by some marketing guru trying to sell snake oil.

I recommend a little more patience because we are now only months ( may be 12 ) away from that defining Data.

Chester.

The truth is that we have invested in a science based company, run by scientists and the science is their paramount concern.
The core ethic of Scancell has nothing to do with the impatience of money driven investors.

Very frustrating for anyone who has put in hard earned cash but that's the truth of it.

However.......

when that science driven diligence actually starts to heal gravely Ill patients and becomes the envy of the worlds pharmaceutical industry the long suffering PI will be handsomely repaid ............

Chester.

Scarlett2020

Thank you for your candid reply, my thoughts entirely and I've always tried to see past these growing pains and where the company can be in 3 to 5 years.

If it came to a placing I would be at the front of the queue because the money they received would finance them past the current output restraints.

Chester

Thank Inan

I think you you have said a few times in the past that Autoimmune is the other side of the coin to how Cancer works.
One tries to calm the immune response and hide and the other over simulates the immune response.

So Scancells understanding of the interactions involved in binding processes is now being sought by the science community battling Autoimmune diseases.

Chester.

Hi Inanaco

Do you think it could that have anything to do with the Karolinska Institute collaboration ?

Chester

Hi Scarlett2020

Welcome to the TRX discussion board. I've been holding TRX shares since late 2014 and I have every confidence that the current BOD have the necessary experience and industry contacts to find a suitable finance package.

May I ask, you are a recent poster but you do come across as having a good knowledge of the current TRX position and you do seem confident, almost 'in the know' confident, so can you say what your background or interest stems from in Tissue Regenix ?

Thank you

Chester.

Hi Jerryspaniel

Thanks for your post but No not you, yours was just an observation it was Olderandwiser.

I kind of new what I was trying to say but he did jump in with both feet, condemned me as a numpty without be given a chance.

Chester.

Morning Olderandwiser

I think you owe me an apology

Chester.

So for anyone that read my post where I asked about the possible conversion of the warrants giving GGP some Scallywag drilling cash and I got a right 'slap down' by one poster. It turns out I was actually thinking intelligently but was made to feel like a real stupid upstart.

Why do people have to be so aggressive in their reply's when a genuine question is asked, we are all here to learn and enjoy the Greatland Gold adventure.

Chester.

Olderandwiser,

My earlier comment was from a lack of full understanding but on the 4th Feb an RNS was released about a Block Listing.
The RNS stated :

"Following admission, the Company's issued share capital remains unchanged at 3,577,233,658 ordinary shares of 0.1p each. The Company will make six-monthly announcements of the utilisation of the Block Admission, in line with its obligations under AIM Rule 29."

I wrongly used the term Treasury, what I was referring to was what I remember being talked about at the time and that was the above statement.

There was no need for you to be so unkind in your comments.

So can you please explain to me what the above statement actually means if it does not mean that warrants could have been converted and we will not know until told in six months, and please try to be polite.

Chester.

Olderandwiser

Ok you may not be older but your definitely wiser. I thought the shares were already issued and held in treasury.
So much to learn about the way companies raise cash and how the warrants work.

So thank you.

Chester.

Hi Dessertrader

I wasn't to sure what GGP had left in the kitty
Or just how much a short drilling campaign can cost. So thank you for your post.

Chester.

Hi OlderandWiser

How do you know that no warrants were converted we will not be told for six months and on the day that the warrants could be converted there was a mass of high value buys and sells.

So how can you be confident that mo warrants were converted?

Chester.